Natural Products Inspire the Design of Molecular Agents Against Drug-Resistant Bacterial Strains


Many microorganisms produce secondary natural products, the potential antibiotic effects of which are extensively investigated. German scientists have now examined a class of quinone-like substances containing an additional epoxide functional group for their antibiotic activities. As they report in the journal Angewandte Chemie, the compounds can kill problematic Salmonella pathogens, probably by interfering with their bacterial stress response system.

Multidrug resistance is one of the most urgent problems in clinical research. It particularly concerns the gram-negative bacteria strains, which possess an outer membrane largely impermeable for small molecules. Scientists are continually screening natural secondary products of various structural motifs to investigate their effects as possible antibiotics, which could enter in the microorganism and possibly inhibit essential enzymes. Stephan Sieber, Iris Antes and their colleagues at Technical University of Munich were particularly interested in a class of molecules with a structural scaffold present in various natural products. Its quinone-epoxide motif could be crucial for antibacterial bioactivity, they assumed.

The scientists used click chemistry to label the molecular candidates with fluorescent dyes. Thus, in a proteomic approach, their--at this point unknown--protein targets within the microorganisms could be identified, once they interacted with the candidates. One of the candidates called FM233 was not only found to kill Salmonella, which is one of the most problematic pathogens, but its target proteins were identified as well. The scientists reported that two of the three proteins belonged to the cellular stress response machinery. "FM233 antibiotic activity stemmed to a large extend from down regulation of enzymatic stress response, and corresponding sensitization of cells to stress," they wrote. The function of the third of the three targeted proteins had been unknown before. However, after employing test systems on various possible activities, the scientists concluded "that this protein is not involved in the antibacterial mechanism of action."

The notion that FM233 can intervene in the bacterial stress response system could be a good starting point for further research on the antibacterial activities of that particular molecular scaffold. As only small chemical changes can cause strong responses, the battle against resistance is ongoing.

Source: Wiley

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content